2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$17.28+$0.02 (+0.12%)
Price as of Jun 23, 2026 7:50 PM EDT- $1.9BMarket Cap
- -6.47%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$17.28+$0.02 (+0.12%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 13.98% | 14.8M | +472,024 (+3.20%) | Mar 31, 2026 |
VANGUARD GROUP INC | 11.19% | 11.8M | +993,283 (+8.41%) | Dec 31, 2025 |
BLACKROCK FUNDING, INC. /DE | 10.60% | 11.2M | +168,672 (+1.51%) | Dec 31, 2024 |
BLACKROCK INC. | 9.78% | 10.3M | +4.4M (+42.27%) | Jun 30, 2024 |
N/A | 6.29% | 6.6M | +6.6M (+100.00%) | Mar 31, 2026 |
STATE STREET CORP | 6.26% | 6.6M | +13,873 (+0.21%) | Mar 31, 2026 |
AQR CAPITAL MANAGEMENT LLC | 6.09% | 6.4M | -1.4M (-21.19%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
CALAMOS INVESTMENT TRUST/IL | 43.82% | 46.3M | 0 (0.00%) | Jan 31, 2026 |
Virtus Strategy Trust | 14.10% | 14.9M | 0 (0.00%) | Sep 30, 2025 |
iSHARES TRUST | 9.08% | 9.6M | +150,357 (+1.57%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 7.57% | 8.0M | +144,942 (+1.81%) | Mar 31, 2026 |
FIDELITY FINANCIAL TRUST | 7.22% | 7.6M | 0 (0.00%) | Feb 28, 2026 |
LORD ABBETT INVESTMENT TRUST | 6.84% | 7.2M | 0 (0.00%) | Feb 28, 2026 |
AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 6.63% | 7.0M | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Mutual Funds1.7B (53.03%)
- Institutions1.5B (46.30%)
- Insiders22.0M (0.67%)
- Other0 (0.00%)
Insider Transactions
- 0.67% (22.0M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 2Number of InsiderSelling (last 12 months)
- $4.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Mayo Stephen | Sell | Mar 12, 2026 | $123,207.78 | 7,239 | $17.02 | 1,765 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 11, 2026 | $16,587.22 | 974 | $17.03 | 137,544 |
Wong Ryan Ho-Yan Chief Financial Officer | In Kind | Mar 11, 2026 | $4,359.68 | 256 | $17.03 | 135,064 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 11, 2026 | $18,681.91 | 1,097 | $17.03 | 201,983 |
Rodino-Klapac Louise President, R&D and Tech Ops | In Kind | Mar 09, 2026 | $8,542.80 | 504 | $16.95 | 227,166 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 09, 2026 | $17,560.20 | 1,036 | $16.95 | 203,663 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 09, 2026 | $8,203.80 | 484 | $16.95 | 138,864 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 09, 2026 | $9,881.85 | 583 | $16.95 | 203,080 |
Rodino-Klapac Louise President, R&D and Tech Ops | In Kind | Mar 09, 2026 | $15,170.25 | 895 | $16.95 | 226,271 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 09, 2026 | $5,864.70 | 346 | $16.95 | 138,518 |
Wong Ryan Ho-Yan Chief Financial Officer | In Kind | Mar 02, 2026 | $7,290.00 | 450 | $16.20 | 135,595 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 02, 2026 | $53,476.20 | 3,301 | $16.20 | 205,574 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 02, 2026 | $6,609.60 | 408 | $16.20 | 139,348 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 02, 2026 | $14,175.00 | 875 | $16.20 | 204,699 |
Estepan Ian Michael Chief Operating Officer | Exempt | Mar 01, 2026 | $0.00 | 8,125 | $0.00 | 0 |
Estepan Ian Michael Chief Operating Officer | Exempt | Mar 01, 2026 | $0.00 | 8,125 | $0.00 | 208,875 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $0.00 | 2,069 | $0.00 | 0 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $0.00 | 5,381 | $0.00 | 0 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $28,365.99 | 2,069 | $13.71 | 195,369 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $73,773.51 | 5,381 | $13.71 | 200,750 |
Rodino-Klapac Louise President, R&D and Tech Ops | Award | Feb 25, 2026 | $0.00 | 1,875 | $0.00 | 8,125 |
Estepan Ian Michael Chief Operating Officer | Award | Feb 25, 2026 | $0.00 | 1,875 | $0.00 | 8,125 |
Nicaise Claude | Exempt | Jan 29, 2026 | $0.00 | 10,500 | $0.00 | 0 |
Nicaise Claude | Exempt | Jan 29, 2026 | $143,955.00 | 10,500 | $13.71 | 38,312 |
Nicaise Claude | In Kind | Jan 29, 2026 | $143,939.40 | 6,780 | $21.23 | 31,532 |
Chambers Michael Andrew | Return | Dec 18, 2025 | $0.00 | 0 | $0.00 | 0 |
Chambers Michael Andrew | Award | Dec 18, 2025 | $0.00 | 0 | $0.00 | 0 |
Estepan Ian Michael Chief Operating Officer | Sell | Dec 16, 2025 | $294,201.97 | 13,187 | $22.31 | 193,300 |
Rodino-Klapac Louise President, R&D and Tech Ops | In Kind | Nov 17, 2025 | $84,400.44 | 4,582 | $18.42 | 224,030 |
Estepan Ian Michael Chief Operating Officer | Award | Sep 03, 2025 | $0.00 | 93,875 | $0.00 | 156,487 |